Krystal Biotech Financial Overview
Krystal Biotech's market cap is currently $6.95B. The company's EPS TTM is $2.66; its P/E ratio is 37.01; Krystal Biotech is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $1.50. See an overview of income statement, balance sheet, and cash flow financials.
